U.K.’s NICE Endorses Low-Cost Statins To Treat Cardiovascular Disease
This article was originally published in The Pink Sheet Daily
Recommendations from the cost-effectiveness agency could make 3.3 mil. people in the U.K. eligible for statin therapy.
You may also be interested in...
Four experts in cardiovascular medicine participated in interviews with "The Tan Sheet" to discuss the U.K.'s decision to switch Merck's cholesterol-lowering drug simvastatin 10 mg behind-the-counter.
Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.
A Phase III trial will compare 40 mg/day glatiramer to the 20 mg/day approved dose.